Breaking News Instant updates and real-time market news.

NFLX

Netflix

$309.25

5.58 (1.84%)

, LLY

Eli Lilly

$80.15

0.855 (1.08%)

10:26
04/13/18
04/13
10:26
04/13/18
10:26

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: Netflix (NFLX) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft saying he underestimated the market's willingness to underwrite several years of negative free cash flow to drive growth. 2. Eli Lilly (LLY) upgraded to Market Perform from Underperform at BMO Capital with analyst Alex Arfaei saying he believes that his previously expressed concerns around the downside risks for Humalog, cautious outlook for Vernezio, and uncertainty around Bari are "mostly reflected" in the stock, with more balance in risk-reward going forward. 3. Willis Towers Watson (WLTW) upgraded to Buy from Hold at Sandler O'Neill with analyst Paul Newsome saying he is making a valuation call with the stock down to "both absolute and relative valuations that we have not seen since there were significant concerns about the Willis/Towers Watson merger and the company's ability to generate organic growth." 4. Shaw Communications (SJR) upgraded to Buy from Hold at Canaccord and to Outperform from Sector Perform at Scotiabank. 5. eBay (EBAY) upgraded to Buy from Neutral at Monness Crespi with analyst Jim Chartier saying eBay's structured data initiatives have meaningfully improved the eBay marketplace experience for buyers and sellers, resulting in gross merchandise value inflecting to up 7% in the fourth quarter of 2017 from up 1% in the third quarter of 2016. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NFLX

Netflix

$309.25

5.58 (1.84%)

LLY

Eli Lilly

$80.15

0.855 (1.08%)

WLTW

Willis Towers Watson

$147.89

0.86 (0.58%)

SJR

Shaw Communications

$20.78

-0.195 (-0.93%)

EBAY

eBay

$40.53

0.7 (1.76%)

  • 16

    Apr

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 07

    May

  • 21

    May

  • 07

    Jun

  • 12

    Jun

NFLX Netflix
$309.25

5.58 (1.84%)

04/12/18
KEYB
04/12/18
NO CHANGE
Target $300
KEYB
Overweight
Growing spending should drive upside to Netflix Q1 subscriber estimates, says KeyBanc
KeyBanc analyst Andy Hargreaves says that an analysis of Netflix's ability to drive subscriber growth through marketing and content spending suggests the potential for upside to our subscriber estimates in Q1 and 2018, and suggests a business with substantial profit potential and growing barriers to entry. The analyst reiterates an Overweight rating and $300 price target on the shares.
04/13/18
DBAB
04/13/18
UPGRADE
Target $350
DBAB
Buy
Deutsche Bank upgrades Netflix to Buy with price target of $350
Deutsche Bank analyst Bryan Kraft upgraded Netflix to Buy from Hold and raised his price target for the shares to $350 from $240. The streaming service closed yesterday up $5.58 to $309.25. The analyst admits he underestimated the market's willingness to underwrite several years of negative free cash flow to drive growth. Netflix has changed the industry in a "profound way" and in doing so has given itself a "significant" lead, making it very difficult for the traditional media companies, or even other big tech companies, to catch up, Kraft tells investors in a research note. He believes Netflix continues to capitalize on this lead by reinvesting in content, marketing, and the user experience. Further, the company's Q1 guidance looks conservative by up to 1M subscribers worldwide, the analyst contends.
04/13/18
WELS
04/13/18
NO CHANGE
Target $345
WELS
Outperform
Netflix price target raised to $345 from $285 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Netflix to $345 from $285 saying his survey of 500 U.S. residents reaffirms the streaming service's pricing power. The survey indicates that based on the level and quality of content Netflix has today, 50% of respondents would pay a higher, and in some instances a much higher, price, Sena tells investors in a research note. The analyst modestly increased his outer-year estimates for Netflix and keeps an Outperform rating on the shares.
04/13/18
DBAB
04/13/18
UPGRADE
DBAB
Buy
Netflix upgraded to Buy from Hold at Deutsche Bank
LLY Eli Lilly
$80.15

0.855 (1.08%)

04/12/18
SBSH
04/12/18
NO CHANGE
SBSH
Sell
Pfizer has no interest in acquiring Bristol-Myers right now, says Citi
Citi analyst Andrew Baum says Pfizer's (PFE) CEO made it clear to him that the company has no interest in acquiring Bristol-Myers Squibb (BMY) in the absence of transformational data or a de-rating in the shares. Pfizer has high conviction in its current pipeline and believes that the return on investment is considerably higher than high risk transformational deals, particularly in the immuno-oncology space, Baum tells investors in a research note. The analyst expects Pfizer will meaningfully increase its current share repurchase program from the current $5B-$6B per annum to offset the earnings dilution from higher anticipated R&D investment to monetize its current pipeline. Baum keeps a Sell rating on Pfizer and continues to prefer shares of Merck (MRK), Bristol and Eli Lilly (LLY) in the U.S. The analyst lowered his price target for Bristol shares to $70 from $78 with Pfizer backing away from a potential takeover. He keeps a Buy rating on the shares, however.
04/13/18
BMOC
04/13/18
UPGRADE
Target $79
BMOC
Market Perform
Eli Lilly upgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform from Underperform and raised his price target to $79 from $74. The analyst believes that his previously expressed concerns around the downside risks for Humalog, cautious outlook for Vernezio, and uncertainty around Bari are "mostly reflected" in the stock, with more balance in risk-reward going forward. While he anticipates 2018 to be volatile as maturing diabetes franchise constrains the company's growth plans, Arfaei also sees some tailwinds for Eli Lilly around continued strong growth of Trulicity, further growth of Taltz, Jardiance, and Basglar, as well as potential divestiture of Elanco.
04/05/18
RHCO
04/05/18
NO CHANGE
Target $101
RHCO
Buy
Eli Lilly supported by positive oncology and diabetes findings, says SunTrust
SunTrust analyst John Boris keeps his Buy rating and $101 price target on Eli Lilly (LLY), citing the latest developments in Oncology and Diabetes. In Oncology, Boris points to the positive Overall Survival and Progression Free Survival data for Cyramza in second-line hepatocellular carcinoma, though he sees the commercial opportunity in Hepatocellular Carcinoma as limited. In Diabetes, the analyst points to the latest data showing Trulicity gaining market share on Novo Nordisk's (NVO) Victoza in the GLP-1 market.
04/13/18
BMOC
04/13/18
UPGRADE
Target $79
BMOC
Market Perform
Eli Lilly upgraded to Market Perform from Underperform at BMO Capital
BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform and raised his price target for the shares to $79 from $74.
WLTW Willis Towers Watson
$147.89

0.86 (0.58%)

04/13/18
SDLR
04/13/18
UPGRADE
Target $163
SDLR
Buy
Willis Towers Watson upgraded to Buy on valuation at Sandler O'Neill
Sandler O'Neill analyst Paul Newsome upgraded Willis Towers Watson to Buy from Hold with an unchanged price target of $163. The analyst is making a valuation call with the stock down to "both absolute and relative valuations that we have not seen since there were significant concerns about the Willis/Towers Watson merger and the company's ability to generate organic growth." He views Willis Towers Watson's valuation as inexpensive relative to peers.
03/26/18
BOFA
03/26/18
DOWNGRADE
Target $163
BOFA
Underperform
Willis Towers Watson downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Jay Cohen downgraded Willis Towers Watson to Underperform after having reconstituted the firm's coverage structure to include both the Life and Non-Life names and concluding that the stock falls in the Underperform range on a total return basis compared to that group. While Willis' organic growth rebounded in 2017, its inconsistent margin performance detracts a bit from his confidence in the company's near-term earnings power, said Cohen, who has a $163 price target on the stock.
03/26/18
03/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Adobe (ADBE) downgraded to Market Perform from Outperform at JMP Securities with analyst Patrick Walravens saying he believes the shares are fairly valued after having risen 69% in 2017 and a further 21% year-to-date. 2. Dover (DOV) downgraded to Neutral from Overweight at JPMorgan with analyst Steve Tusa saying a lack of near-term catalysts makes the risk/reward profile no longer attractive. 3. AMD (AMD) downgraded to Negative from Neutral at Susquehanna with analyst Christopher Rolland saying he confirmed Bitmain has developed an ASIC for Ethereum mining, which he believes accounted for roughly 20% of AMD's sales. 4. Jack in the Box (JACK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst John Glass saying he sees limited upside and ongoing top-line risk. 5. Willis Towers Watson (WLTW) downgraded to Underperform from Neutral at BofA/Merrill with analyst Jay Cohen saying while Willis' organic growth rebounded in 2017, its inconsistent margin performance detracts a bit from his confidence in the company's near-term earnings power. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/13/18
SDLR
04/13/18
UPGRADE
SDLR
Buy
Willis Towers Watson upgraded to Buy from Hold at Sandler O'Neill
SJR Shaw Communications
$20.78

-0.195 (-0.93%)

04/13/18
ADAM
04/13/18
UPGRADE
ADAM
Buy
Shaw Communications upgraded to Buy from Hold at Canaccord
04/13/18
SCOT
04/13/18
UPGRADE
SCOT
Outperform
Shaw Communications upgraded to Outperform from Sector Perform at Scotiabank
01/12/18
TDSI
01/12/18
UPGRADE
TDSI
Action List Buy
Shaw Communications upgraded to Action List Buy from Buy at TD Securities
TD Securities analyst Vince Valentin upgraded Shaw Communications to Action List Buy. Valentin soft Q1 results were expected, but management signaled that wireless subscriber additions could accelerate in Q2, marking a breakout quarter in wireless growth.
04/12/18
LEHM
04/12/18
UPGRADE
LEHM
Overweight
Shaw Communications upgraded to Overweight from Equal Weight at Barclays
EBAY eBay
$40.53

0.7 (1.76%)

04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
KEYB
04/11/18
INITIATION
Target $50
KEYB
Overweight
eBay assumed with an Overweight at KeyBanc
KeyBanc analyst Edward Yruma assumed coverage of eBay with an Overweight rating and $50 price target. The company has successfully transitioned to a "destination for compelling prices," and initiatives to enhance customer experience and attract brands should lead to continued gross merchandise acceleration in 2018, Yruma tells investors in a research cote. The analyst thinks consumers are increasingly turning to eBay as a destination for deals.
04/12/18
BARD
04/12/18
NO CHANGE
Target $52
BARD
Outperform
eBay volume finishes strong in Q1, says Baird
Baird analyst Colin Sebastian said March volumes for eBay showed a strong finish to Q1 as year-over-year volume growth accelerated. He also noted faster growth continued into the first week of April, with the ongoing strength possibly attributed to more aggressive promotional activity. Sebastian reiterated his Outperform rating and $52 price target on eBay shares.
04/13/18
MONN
04/13/18
UPGRADE
Target $48
MONN
Buy
eBay upgraded to Buy from Neutral at Monness Crespi
Monness Crespi transferred eBay coverage to Jim Chartier who upgraded shares to Buy from Neutral and established a $48 price target. Chartier said eBay's structured data initiatives have meaningfully improved the eBay marketplace experience for buyers and sellers, resulting in gross merchandise value inflecting to up 7% in Q4 2017 from up 1% in Q3 2016. The analyst expects high single digit sales or better going forward driven by marketplace acceleration and solid growth from StubHub and Classifieds, combined with continued share repurchases, which will grow earnings in the low double digits or mid-teens.

TODAY'S FREE FLY STORIES

CCRC

China Customer Relations Centers

$8.61

-0.46 (-5.07%)

07:33
07/23/18
07/23
07:33
07/23/18
07:33
Hot Stocks
China Customer Relations Centers not aware of reasons for recent volatility »

China Customer Relations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTX

Leap Therapeutics

$8.29

-0.23 (-2.70%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

07:33
07/23/18
07/23
07:33
07/23/18
07:33
Hot Stocks
Leap Therapeutics announces collaboration with Merck KGaA, Pfizer »

Leap Therapeutics (LPTX)…

LPTX

Leap Therapeutics

$8.29

-0.23 (-2.70%)

MKGAY

Merck KGaA

$0.00

(0.00%)

PFE

Pfizer

$37.33

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

BLKB

Blackbaud

$117.74

1.31 (1.13%)

07:33
07/23/18
07/23
07:33
07/23/18
07:33
Initiation
Blackbaud initiated  »

Blackbaud initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

07:32
07/23/18
07/23
07:32
07/23/18
07:32
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTR

Nutrien

$52.43

0.43 (0.83%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Hot Stocks
Nutrien seels equity state in Arab Potash Company »

Nutrien announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.52

0.03 (0.16%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Hot Stocks
Amneal receives FDA approval on ANDA for Potassium Chloride solution »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FTSV

Forty Seven

$15.80

0.1 (0.64%)

07:31
07/23/18
07/23
07:31
07/23/18
07:31
Initiation
Forty Seven initiated  »

Forty Seven initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$92.95

3.74 (4.19%)

, EXPE

Expedia

$125.50

-2.34 (-1.83%)

07:30
07/23/18
07/23
07:30
07/23/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

VFC

VF Corp.

$92.95

3.74 (4.19%)

EXPE

Expedia

$125.50

-2.34 (-1.83%)

PVG

Pretium Resources

$8.37

0.115 (1.39%)

TSN

Tyson Foods

$64.14

-0.76 (-1.17%)

SN

Sanchez Energy

$4.68

-0.14 (-2.90%)

NYCB

New York Community Bancorp

$11.41

-0.025 (-0.22%)

AN

AutoNation

$48.59

-0.75 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 28

    Oct

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$104.35

-0.3 (-0.29%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 05

    Sep

  • 06

    Sep

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SNAP

Snap

$13.27

-0.155 (-1.16%)

, SQ

Square

$70.41

0.11 (0.16%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Periodicals
Snap to shutdown Snapcash, end partnership with Square, TechCrunch reports »

Snap (SNAP) will end its…

SNAP

Snap

$13.27

-0.155 (-1.16%)

SQ

Square

$70.41

0.11 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VFC

VF Corp.

$92.95

3.74 (4.19%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.65

0.49 (0.27%)

, P

Pandora

$8.20

0.005 (0.06%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Initiation
Spotify, Pandora initiated  »

Spotify initiated with a…

SPOT

Spotify

$182.65

0.49 (0.27%)

P

Pandora

$8.20

0.005 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

  • 14

    Aug

SHOP

Shopify

$171.72

0.04 (0.02%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
Shopify analyst commentary  »

Shopify price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BIIB

Biogen

$358.72

0.55 (0.15%)

07:26
07/23/18
07/23
07:26
07/23/18
07:26
Recommendations
Biogen analyst commentary  »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

07:25
07/23/18
07/23
07:25
07/23/18
07:25
General news
FX Update: The Dollar recovered losses »

FX Update: The Dollar…

GDDY

GoDaddy

$78.49

0.25 (0.32%)

07:24
07/23/18
07/23
07:24
07/23/18
07:24
Recommendations
GoDaddy analyst commentary  »

GoDaddy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:23
07/23/18
07/23
07:23
07/23/18
07:23
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WCG

WellCare

$256.13

0.545 (0.21%)

07:22
07/23/18
07/23
07:22
07/23/18
07:22
Initiation
WellCare initiated  »

WellCare initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MOH

Molina Healthcare

$106.16

0.64 (0.61%)

07:20
07/23/18
07/23
07:20
07/23/18
07:20
Initiation
Molina Healthcare initiated  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 21

    Aug

07:20
07/23/18
07/23
07:20
07/23/18
07:20
General news
Treasury Market Outlook: Treasury yields have dipped lower »

Treasury Market Outlook:…

CNC

Centene

$135.45

0.175 (0.13%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 10

    Aug

  • 23

    Oct

  • 14

    Dec

OMER

Omeros

$19.63

-0.42 (-2.09%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Hot Stocks
Omeros initiates sales of Omidria in Europe, satisfies 'sunset clause' »

Omeros announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.